Karuna Therapeutics announced the appointment of Bill Meury as president and CEO and a member of the company’s board, effective January 3, 2023. Meury will succeed Steve Paul, M.D., the current president, CEO and chairman, who will transition to president of research and development and chief scientific officer and continue to serve as a member of the board following the effective date. At that time, Christopher Coughlin, the company’s lead independent director, will assume the role of chairman of the board. Most recently, Meury served as a partner at Hildred Capital Management, a private equity firm focusing on the healthcare industry.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly